Therapeutic inferences for individual patients

Journal of Evaluation in Clinical Practice

Volumn 21, Issue 3, 2015, Pages 440-447

  Flores, Luis ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

clinical judgment; evidence based medicine; extrapolation; inference; logic; therapeutic reasoning

Indexed keywords

ARTICLE; AWARENESS; CLINICAL DECISION MAKING; CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; HUMAN; LOGIC; MEDICAL PRACTICE; PRIORITY JOURNAL; PROBABILITY; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; HUMANS; PROBABILITY; TREATMENT OUTCOME;

EID: 84928775663     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12293     Document Type: Article

References (63)

1. Straus, S. E., Glasziou, P., Richardson, W. S., &, Haynes, R. B., (2011) Evidence-Based Medicine: How to Practice and Teach It, 4th edn. New York: Churchill-Livingstone.
2. Guyatt, G., Rennie, D., Meade, M. O., &, Cook, D. J., (2008) Users' Guides to the Medical Literature: A Manual for Evidence Based Clinical Practice, 2nd edn. New York: McGraw-Hill.
3. Windish, D., (2013) Searching for the right evidence: how to answer your clinical questions using the 6S hierarchy. Evidence-based Medicine, 18, 93-97.
4. Haynes, R. B., (2002) What kind of evidence is it that evidence-based medicine advocates want health care providers and consumers to pay attention to? BMC Health Services Research, 2 (1), 3.
5. Rothwell, P. M., (2007) When should we expect clinically important differences in response to treatment? In Treating Individuals: From Randomised Trials to Personalised Medicine (ed., P. M. Rothwell,), pp. 139-150. Edinburgh: Elsevier.
6. Post, P. N., de Beer, H., &, Guyatt, G. H., (2013) How to generalize efficacy results of randomized trials: recommendations based on a systematic review of possible approaches. Journal of Evaluation in Clinical Practice, 19, 638-643.
7. Guyatt, G. H., Oxman, A. D., Vist, G. E., et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal, 336, 924-926.
8. Zwolsman, S. E., van Dijk, N., &, Wieringa de Waard, M., (2013) Observations of Evidence-Based Medicine in general practice. Perspectives in Medical Education, 2, 196-208.
9. Greenhalgh, T., Howick, J., Maskrey, N., & Evidence Based Medicine Renaissance Group (2014) Evidence based medicine: a movement in crisis? British Medical Journal, 348, g3725 doi: http://dxdoi.org/10.1136/bmj.g3725.
10. Goldenberg, M., (2009) Iconoclast of creed? Objectivism, pragmatism, and the hierarchy of evidence. Perspectives in Biology & Medicine, 52 (2), 168-187.
11. Fuller, J., (2013) Rhetoric and argumentation: how clinical practice guidelines think. Journal of Evaluation of Clinical Practice, 19 (3), 433-441.
12. Mason, A., (2008) New medicines in primary care: a review of influences on general practitioner prescribing. Journal of Clinical Pharmacy and Therapeutics, 33 (1), 1-10.
13. Giacomi, M., (2009) Theory-based medicine and the role of evidence: why the emperor needs new clothes again. Perspectives in Biology & Medicine, 52 (2), 234-251.
14. Upshur, R. E. G., &, Colak, E., (2003) Argumentation and evidence. Theoretical Medicine, 24 (4), 283-299.
15. Lewis, P. J., &, Tully, M. P., (2009) The discomfort of an evidence-based prescribing decision. Journal of Evaluation of Clinical Practice, 15 (6), 1152-1158.
16. Cranney, M., Warren, E., Barton, S., Gardner, K., &, Walley, T., (2001) Why do GPs not implement evidence-based guidelines? A descriptive study. Family Practice, 18 (4), 359-363.
17. Lipman, T., Murtagh, M. J., &, Thomson, R., (2004) How research-conscious GPs make decisions about anticoagulation in patients with atrial fibrillation: a qualitative study. Family Practice, 21 (3), 290-298.
18. Summerskill, W. S. M., &, Pope, C., (2002) 'I saw the panic rise in her eyes, and evidence- based medicine went out of the door.' An exploratory qualitative study of the barriers to secondary prevention in the management of coronary heart disease. Family Practice, 19 (6), 605-610.
19. Karve, A., Ou, F., Lytle, B., &, Peterson, E., (2008) Potential unintended financial consequences of pay-for-performance on the quality of care for minority patients. American Heart Journal, 155 (3), 571-576.
20. Shackelton, R. J., Marceau, L. D., Link, C. L., &, McKinlay, J. B., (2009) The intended and unintended consequences of clinical guidelines. Journal of Evaluation of Clinical Practice, 15 (6), 1035-1042.
21. Hurwitz, B., (2013) Confessional ruminations on an ocular cure testimonial. Atrium, 11 (3), 12-15.
22. Drug and Therapeutics Bulletin (2011) Management of acute infective conjunctivitis. Drug and Therapeutics Bulletin, 49 (7), 78-81.
23. Steeples, L., &, Mercieca, K., (2012) Acute conjunctivitis in primary care: antibiotics and placebo associated with small increase in the proportion cured by 7 days compared with no treatment. Evidence-Based Medicine, 17 (6), 177-178.
24. Jefferis, J., Perera, R., Everitt, H., van Weert, H., Rietyeld, R., Glasziou, P., &, Rose, P., (2011) Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. The British Journal of General Practice, 61 (590), e542-e548.
25. Sheikh, A., &, Hurwitz, B., (2006) Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database of Systematic Reviews, 19 (2), CD001211.
26. Postema, E. J., Remeijer, L., &, Van del Meijden, W. I., (1996) Epidemiology of genital chlamydial infections in patients with chlamydial conjunctivitis; a retrospective study. Geniturinary Medicine, 72 (3), 203-205.
27. Biebesheimer, J. B., House, J., Hong, K. C., et al. (2009) Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions. Ophthalmology, 116 (11), 2047-2050.
28. Garland, S. M., Malatt, A., Tabrizi, S., Grando, D., Lees, M. I., Andrew, J. H., &, Taylor, H. R., (1995) Chlamydia trachomatis conjunctivitis. Prevalence and association with genital tract infection. Medical Journal of Australia, 162 (7), 363-366.
29. Carnap, R., (1947) On the application of inductive logic. Philosophy and Phenomenological Research, 8, 133-148.
30. Smith, J. K., (2010) Bayesian decision analysis. Principles and practice. Cambridge: Cambridge University Press.
31. Good, I. J., (1983) Good Thinking. The Foundations of Probability and Its Applications. Minneapolis: The University of Minnesota Press.
32. Gensler, H. J., (2002) Introduction to Logic. London/New York: Routledge.
33. Hacking, I., (2001) An Introduction to Probability and Inductive Logic. Cambridge: Cambridge University Press.
34. Polychronis, A., Miles, A., &, Bentley, P., (1996) Evidence-based medicine: reference? Dogma? Neologism? New orthodoxy. Journal of Evaluation of Clinical Practice, 2 (1), 1-3.
35. Greenfield, S., Kravitz, R., Duan, N., &, Kaplan, S. H., (2007) Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment. American Journal of Medicine, 120, S3-S9.
36. Summerskill, W. S. M., (2005) Evidence-based practice and the individual. The Lancet, 365 (1), 13-14.
37. Rothwell, P. M., (1995) Can overall results of clinical trials be applied to all patients? The Lancet, 345, 1616-1619.
38. Kent, D. M., &, Hayward, R. A., (2007) Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. Journal of the American Medical Association, 298, 1209-1212.
39. Glasziou, P. P., &, Irwig, L. M., (1995) An evidence based approach to individualising treatment. British Medical Journal, 311, 1356-1359.
40. Oxman, A., Guyatt, G., Cook, D., &, Montori, V., (2002) Summarizing the evidence. In Users' Guides to the Medical Literature: A Manual of Evidence-Based Clinical Practice (eds, G. Guyatt, &, D. Rennie,), p. 169. Chicago: American Medical Association.
41. Chalkidou, K., Tunis, S., Whicher, D., Fowler, R., &, Zwarenstein, M., (2012) The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research. Clinical Trials, 9 (4), 436-446.
42. Thorpe, K. E., Zwarenstein, M., Oxman, A. D., et al. (2009) A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. Journal of Clinical Epidemiology, 62, 464-475.
43. Sun, X., Ioannidis, J. P., Agoritsas, T., Alba, A. C., &, Guyatt, G., (2014) How to use a subgroup analysis: users' guide to the medical literature. Journal of the American Medical Association, 311 (4), 405-411.
44. Goodwin, M., Ruhland, L., Casson, I., MacDonald, S., Delva, D., Birtwhistle, R., Lam, M., &, Seguin, R., (2003) Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Medical Research Methodology, 22 (3), 28. doi: 10.1186/1471-2288-3-28.
45. Fortin, M., Dionne, J., Pinho, G., Gignac, J., Almirall, J., &, Lapointe, L., (2006) Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Annals of Family Medicine, 4 (2), 104-108.
46. Uijen, A. A., Bakx, J. C., Mokkink, H. G., &, van Weel, C., (2007) Hypertension patients participating in trials differ in many aspects from patients treated in general practices. Journal of Clinical Epidemiology, 60 (4), 330-335.
47. Travers, J., Marsh, S., Williams, M., Weatherall, M., Caldwell, B., Shirtcliffe, P., Aldington, S., &, Beasley, R., (2007) External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax, 62 (3), 219-223.
48. Rothwell, P. M., (2005) External validity of randomised controlled trials: to whom do the results of this trial apply? The Lancet, 365, 82-93.
49. Valori, R. M., (2002) 'Sampling and applicability'. In Key Topics in Evidence-Based Medicine (eds, D. P. M. McGovern, R. M. Valori, W. S. M. Summerskill, &, M. Levi,), pp. 130-132. Oxford: Bios.
50. Longford, N. T., (1999) Selection bias and treatment heterogeneity in clinical trials. Statistics in Medicine, 18 (12), 1467-1474.
51. Sculpher, M., (2010) Reflecting heterogeneity in patient benefits: the role of subgroup analysis with comparative effectiveness. Value in Health, 13 (1), 18-21.
52. Oxman, A. D., &, Guyatt, G. H., (1992) A consumer's guide to subgroup analyses. Annals of Internal Medicine, 116 (1), 78-84.
53. Senn, S., (2004) Individual response to treatment: is it a valid assumption? British Medical Journal, 329, 966-968.
54. Senn, S., &, Harrell, F., (1997) On wisdom after the event. Journal of Clinical Epidemiology, 50 (7), 749-751.
55. Freemantle, N., (2001) Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? British Medical Journal, 322 (7292), 989-991.
56. Parker, A. B., &, Naylor, C. D., (2000) Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials. American Heart Journal, 139 (6), 952-961.
57. Yusuf, S., Wittes, J., Probstfield, J., &, Tyroler, H. A., (1991) Analysis and interpretation of treatment effects in subgroups of patients in randomized trials. Journal of the American Medical Association, 266 (1), 93-98.
58. Cartwright, N., (2011) Predicting what will happen when we act. What counts for warrant? Preventive Medicine, 53 (4-5), 221-224.
59. Petticrew, M., Tugwell, P., Kristjansson, E., Oliver, S., Ueffing, E., &, Welch, V., (2012) Damned if you do, damned if you don't: subgroup analysis and equity. Journal of Epidemiology & Community Health, 66 (1), 95-98.
60. Kravitz, R. L., Duan, N., &, Braslow, J., (2004) Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. The Milbank Quarterly, 82 (4), 661-687.
61. Sorensen, T. I. A., (1996) Which patients may be harmed by good treatments? The Lancet, 348 (9024), 351-352.
62. Ramsey, F. P., (1990) Weight or the value of knowledge. British Journal for the Philosophy of Science, 41, 1-4.
63. Good, I. J., (1967) On the principle of total evidence. British Journal for the Philosophy of Science, 17, 319-321.